2023 North America Conference on Lung Cancer (NACLC) - Posters and Abstracts-PP01.064 Maxwell Akanbi NACLC23 Abstract

PP01.064 Maxwell Akanbi NACLC23 Abstract

Pdf Summary

This study aimed to investigate the disparities in survival rates for metastatic non-small cell lung cancer (mNSCLC) in the United States, specifically focusing on the impact of advanced therapies. The researchers analyzed data from 153,662 adults with mNSCLC between 2004 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database.<br /><br />The findings revealed that overall survival rates improved for all subgroups, but some experienced greater improvements than others. Women had consistently higher survival rates than men, and the gap between Black and White patients narrowed over time. However, if current trends persist, the survival gap between these racial groups may widen again.<br /><br />Additionally, the study identified residence as a critical factor in disparity, with survival rates among rural dwellers lower than those in urban areas. Furthermore, the gap in survival between urban and rural dwellers widened from 4% in 2004 to 6% in 2017.<br /><br />These findings highlight the importance of targeted therapies and immunotherapy in improving survival rates for mNSCLC patients. However, they also underscore the need to address disparities in access to and delivery of oncology services, particularly for rural populations. The researchers emphasize the development of innovative care delivery models to bridge this gap and ensure equitable access to advanced therapies.<br /><br />In conclusion, while advancements in therapy have led to improved survival rates for mNSCLC patients in the US, disparities based on gender, race/ethnicity, and residence type persist. Efforts should be made to further reduce these disparities and ensure that all patients have equal access to optimal care.

Keywords

metastatic non-small cell lung cancer

survival rates

disparities

advanced therapies

gender

race/ethnicity

residence

rural dwellers

urban areas

oncology services